MENU
+Compare
NVS
Stock ticker: NYSE
AS OF
Jun 27 closing price
Price
$120.01
Change
-$0.31 (-0.26%)
Capitalization
197.93B

NVS Novartis AG Forecast, Technical & Fundamental Analysis

Novartis develops and manufactures innovative drugs... Show more

NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVS with price predictions
Jun 27, 2025

NVS in upward trend: 10-day moving average crossed above 50-day moving average on May 27, 2025

The 10-day moving average for NVS crossed bullishly above the 50-day moving average on May 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 311 cases where NVS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NVS moved out of overbought territory on June 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVS as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NVS turned negative on June 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.200) is normal, around the industry mean (5.632). P/E Ratio (23.383) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (5.223) is also within normal values, averaging (3.004). Dividend Yield (0.039) settles around the average of (0.161) among similar stocks. P/S Ratio (4.299) is also within normal values, averaging (3.643).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVS is expected to report earnings to rise 1.32% to $2.31 per share on July 17

Novartis AG NVS Stock Earnings Reports
Q2'25
Est.
$2.31
Q1'25
Beat
by $0.20
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.13
The last earnings report on April 29 showed earnings per share of $2.28, beating the estimate of $2.08. With 1.54M shares outstanding, the current market capitalization sits at 197.93B.
A.I.Advisor
published Dividends

NVS paid dividends on March 20, 2023

Novartis AG NVS Stock Dividends
А dividend of $3.70 per share was paid with a record date of March 20, 2023, and an ex-dividend date of March 09, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health care and nutritional products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lichtstrasse 35
Phone
+41 613241111
Employees
76057
Web
https://www.novartis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
JUV.X0.9268510.007767
+0.85%
Juventus Fan Token cryptocurrency
HQY104.880.02
+0.02%
HealthEquity
TASK16.76-0.03
-0.18%
TaskUs
BWB16.10-0.09
-0.56%
Bridgewater Bancshares
XEM.X0.004539-0.000703
-13.41%
NEM cryptocurrency

NVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with GSK. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
-0.26%
GSK - NVS
65%
Loosely correlated
+0.08%
AZN - NVS
63%
Loosely correlated
-0.31%
JNJ - NVS
55%
Loosely correlated
+0.26%
PFE - NVS
54%
Loosely correlated
-0.21%
AMGN - NVS
49%
Loosely correlated
-0.71%
More